Clinical trial
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (the NEAR-2 Study: Near Eye-vision Acuity Restoration)
NCT04599972 is registered in ClinicalTrials.gov with Orasis Pharmaceuticals Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (the NEAR-2 Study: Near Eye-vision Acuity Restoration)
- Lead sponsor
- Orasis Pharmaceuticals Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 26, 2020
- Completion date
- January 28, 2022
- Enrollment
- 304 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.